Abstract
Perhaps at the beginningof this discussion we should give reasons why we are interested in knowing the mechanisms of action of these antibiotics. On the one hand we are interested for purely academic reasons, that is, to satisfy man’s inquisitive nature and to add to his storehouse of knowledge. This inquisitiveness leads us to ask such questions as the following:
-
Why is a material that is produced by one organism toxic to another organism?
-
Can these toxic effects be prevented or overcome?
-
Are the various toxic materials toxic for the same reason?
-
Why are some organisms not affected by these agents while other organisms are killed by them?
-
Why are some tissues or cells within an organism affected by the agents while other tissues and cells are not?
-
How do organisms become resistant to an initially toxic agent?
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aaronson, S. 1959 Mode of action of azaserine on Gaffkya homari. J. Bact., 77, 548.
Anderson, E. P., Levenberg, B., and Law, L. W. 1957 Purine biosynthesis in azaserine-sensitive and -resistant lines of the mouse plasma cell neoplasm 70429. Fed. Proc., 16, 145.
Barclay, R. K., Garfinkel, E., and Phillipps, M. 1956 Effects of DON on incorporations of precursors into nucleic acids. Proc. Am. Assoc. Cancer Research, 2, 93.
Bennett, L. L., Jr., Schabel, F.M.,Jr., and Skipper, H. E. 1956 Studies on the mode of action of azaserine. Arch. Biochem. and Biophys., 64, 423.
Bentley, M., and Abrams, R. 1956 Amide-N of glutamine as source of guanine amino group. Fed. Proc., 15, 218.
Bortle, L., and Oleson, J.J. 1955 Effect of puromycin on Tetrahymena pyriformis nutrition. Antibiotics Annual 1954–55, 770.
Buchanan, J.M. 1958 The interference of azaserine in purine biosynthesis, in “Amino Acids and Peptides with Antimetabolic Activity,” CibaSymposium, J. and A. Churchill, Ltd., London, 75–81.
Burchenal, J. H., Holmberg, E.A.D., Reilly, H. C., Hemphill, S., and Reppert, J. A. 1959 The effects of actinobolin on transplanted mouse leukemias. Antibiotics Annual 1958–59, 528.
Clarke, D. A., Reilly, H. C., and Stock, C. C. 1957 A comparative study of 6-diazo-5-oxo- L-norleucine and O-diazoacetyl-L-serine on sarcoma 180. Antibiot. and Chemotherapy, 7, 653.
Dagg, C. P., and Karnofsky, D. A. 1956 Protection against teratogenic action of azaserine and DON. Fed. Proc., 15, 238.
Davis, J. C., and Mudd, S. 1956 Cytological effects of ultraviolet radiation and azaserine on Corynebacterium diphtheriae. J. Gen. Microbiol., 14, 527.
DiPaolo, J. A., Moore, G. E., and Niedbala, T. F. 1957 Experimental studies with actinomycin D. Cancer Research, 17, 1127.
Eidinoff, M. L., Knoll, J. E., Marano, B., and Cheong, L. 1958 Pyrimidine studies. I. Effect of DON (6-diazo-5-oxo-L-norleucine) on incorporation of precursors into nucleic acid pyrimidines. Cancer Research, 18, 105.
Farber, S. 1958 Clinical and biological studies with actinomycins, in “Amino Acids and Peptides with Antimetabolic Activity,” Ciba Symposium, J. and A. Churchill Ltd., London, 138–145.
Foley, G. E. 1956 Preliminary observations on the mechanism of action of actinomycin D in microbiologic systems. Antibiotics Annual 1955–56, 432.
Goldthwait, D. A. 1957 Purine nucleotide biosynthesis and neoplasia, in “Henry Ford Hospital International Symposium on the Leukemias: Etiology, Pathophysiology, Treatment,” pp. 555–565. Edited by J. W. Rebuck, F. H. Bethell, and R. W. Monto, Academic Press, Inc., New York.
Gots, J.S., and Gollub, E. G. 1956 Purine metabolism in bacteria. IV. L-Azaserine as an inhibitor. J. Bact., 72, 858.
Greenlees, J., and LePage, G. A. 1956 Purine biosynthesis and inhibitors in ascites cell tumors. Cancer Research, 16, 808.
Hedegaard, J., Thoai, N-v., and Roche, J. 1959 The influence of histidine on the biosynthesis of purines in Escherichia coli. Arch. Biochem. and Biophys., 83, 183.
Henderson, J. F., LePage, G. A., and Mclver, F.A. 1957 Observations on the action of azaserine in mammalian tissues. Cancer Research, 17, 609.
Hewitt, R.I., Gumble, A. R., Wallace, W.S., andWilliams, J. H. 1954 Experimental chemotherapy of trypanosomiasis. IV. Reversal by purines of the in vivo activity of puromycin, and an amino nucleoside analog, against Trypanosoma equiperdum. Antibiot. and Chemotherapy, 4, 1222.
Kammen, H. O., and Hurlbert, R. B. 1959 The formation of cytidine nucleotides and RNA cytosine from orotic acid by the Novikoff tumor in vitro. Cancer Research, 19, 654.
Kaplan, L., and Stock, C. C. 1954 Azaserine, an inhibitor of amino acid synthesis in Escherichia coli. Fed. Proc., 13, 239.
Karnofsky, D. A., and Bevelander, G. 1958 Effects of DON(6-diazo-5-oxo-L-norleucine) and azaserine on the sand-dollar embryo. Proc. Soc. Exp. Biol, and Med., 97, 32.
Langan, T. A., Jr., Kaplan, N. O., and Shuster, L. 1959 Formation of the nicotinic acid analogue of diphosphopyridine nucleotide after nicotinamide administration. J. Biol. Chem., 234, 2161.
Mascitelli-Coriandoli, E. 1959 Effects of actinomycin-C upon the pyridoxal phosphate contents of the liver. Biochem. Pharmacol., 2, 79.
Maxwell, R. E., and Nickel, V.S. 1954 Filament formation in E. coli induced by azaserine and other antineoplastic agents. Science, 120, 270.
Maxwell, R. E., and Nickel, V.S. 1957 6-Diazo-5-oxo-L-norleucine, a new tumor “inhibitory substance. V. Microbiologic studies of mode of action. Antibiot. and Chemotherapy, 7, 81.
Nakamura, M. 1956 Amoebicidal action of azaserine. Nature, 178, 1119.
Narrtd, S.A., Langan, T.A., Jr., Kaplan, N. O., and Goldin, A. 1959 Effect of azaserine (o-diazoacetyl-L-serine) on the pyridine nucleotide levels of mouse liver. Nature, 183, 1674.
Potter, M., and Law, L.W. 1957 Studies on a plasma-cell neoplasm of the mouse. I. Characterization of neoplasm 70429, including its sensitivity to various antimetabolites with the rapid development of resistance to azaserine, DON, and N-methylformamide. J. Nat. Cancer Inst., 18, 413.
Preiss, J., and Handler, P. 1958 Biosynthesis of diphosphorpyridinenucleotide. II. Enzymatic aspects. J. Biol. Chem., 233, 493.
Raven, H. M., and Hess, G. 1959 Die Wirkung der Actinomycin C und D auf Neurospora crassa. Z. fur Physiolog. Chem., 315, 70.
Reilly, H. C. 1954 The effect of amino acids upon the antimicrobial activity of azaserine. Proc. Am. Assoc. Cancer Research, 1, No. 2, 40.
Reilly, H. C. 1958 Some aspects of azaserine, 6-diazo-5-oxo-L-norleucine, and fl-2- thienylalanine, in “Amino Acids and Peptides with Antimetabolic Activity.” Ciba Symposium, J. and A. Churchill, Ltd., London, 62–74.
Reilly, H. C., Cappuccino, J. G., and Harrison, D. M. 1958 Studies on mitomycin X, A tumor-inhibiting antibiotic. Proc. Am. Assoc. Cancer Research, 2, 338.
Sekiguchi, M., and Takagi, Y. 1959 Synthesis of deoxyribonucleic acid by phage-infected Escherichia coli in the presence of mitomycin C. Nature, 183, 1134.
Shiba, S., Terawaki, A., Taguchi, T., and Kawamata, J. 1959 Selective inhibition of formation of deoxyribonucleic acid in Escherichia coli by mitomycin C. Nature, 183, 1056.
Slotnick, I. J. 1957 Studies on the mechanism of actinomycin D inhibition of Bacillus subtilis. I. Failure to demonstrate pantothenate relationship. Antibiot. and Chemotherapy, 7, 387.
Slotnick, I.J. 1958 Studies on the mechanism of action of actinomycin D. II. Interference with ammonia assimilation and adaptive enzyme formation. Antibiot. and Chemotherapy, 8, 476.
Srinivasan, P. R. 1959 The enzymatic synthesis of anthranilic acid from shikimic acid-5- phosphate and L-glutamine. J. Am. Chem. Soc., 81, 1772.
Thiersch, J. B. 1957a Effect of o-diazck acetyl-L-serine on rat litter. Proc. Soc. Exp. Biol, and Med., 94, 27.
Thiersch, J. B. 1957b Effect of 6-diazo-5-oxo-L-norleucine (DON) on the rat litter in utero. Proc. Soc. Exp. Biol, and Med., 94, 33.
Tomisek, A. J., Kelly, H. J., and Skipper, H. E. 1956 Chromatographic studies of purine metabolism. I. The effect of azaserine on purine biosynthesis in E. coli using various C14-labeled precursors. Arch. Biochem. and Biophys., 64, 437.
Van der Meulen, P. Y. F., and Bassham, J. A. 1959 Study of inhibition of azaserine and diazo-oxo-nor leucine (DON) on the algae Scenedesmus and Chlorella.J. Am. Chem. Soc., 81, 2233.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1960 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wheeler, G.P. (1960). Mechanisms of Action of Anticancer Antibiotics. In: Developments in Industrial Microbiology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-5073-4_14
Download citation
DOI: https://doi.org/10.1007/978-1-4899-5073-4_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-5075-8
Online ISBN: 978-1-4899-5073-4
eBook Packages: Springer Book Archive